Skip to main content
2024 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Back
Video ViewAttendees 48

Malignancy
Symposium

NOM NOM NOM: Why is Anyone Waiting on Watch and Wait?

Monday, June 3, 2024
8:05 AM – 9:05 AM ET, USA
Location: Baltimore Convention Center, Room 314-317

CME Nurses Contact Hours Self-Assessment

    Co-Moderator(s)

  • Rodrigo Perez, MD, PhD

    Chair Colorectal surgery division
    Hospital alemão Oswaldo Cruz
    Hospital Alemão Oswaldo Cruz
    Sao paulo, Sao Paulo, Brazil

    All relevant financial disclosures have been managed and will be listed below.
    This individual has no relevant relationships with ineligible companies.

  • Thomas Curran, MD, MPH

    Associate Professor
    Medical University of South Carolina
    Medical University of South Carolina
    Charleston, South Carolina, United States

    All relevant financial disclosures have been managed and will be listed below.
    This individual has no relevant relationships with ineligible companies.

CME Credit: 1
Self-Assessment Credit: 1
Contact Hours: 1

This symposium will tackle the inherent challenges in organ preservation for patients who achieve a complete clinical response (cCR). Accurate diagnostic criteria of cCR, selection of patients based on baseline features, and preferred treatment strategies will be addressed as well as the specific features of patients who achieve a "near-complete" response including the uncertainties of clear diagnostic criteria and potential risks for organ-preservation strategies for this specific group of patients. Finally, we will address the risk for subsequent distant metastases after achieving a cCR with or without the development of local regrowth.

Learning Objectives:

Upon completion of this activity, participants should be able to:
  • Explain the clinical, endoscopic and radiological features that should be considered for patients potentially candidates for Watch and wait .
  • Recognize the potential benefits and risks associated with organ-preservation strategies for patients who achieve a "near-complete" response to neoadjuvant therapy.
  • Explain the risks for development of distant metastases in patients who achieve a cCR and are managed non-operatively with Watch and Wait.

Presentations:

  • 8:05 AM – 9:05 AM ET, USA
    NOM NOM NOM: Why Is Anyone Waiting on Watch and Wait?

    Co-Moderator: Rodrigo O. Perez, MD, PhD – Hospital alemão Oswaldo Cruz

    Co-Moderator: Thomas Curran, MD, MPH – Medical University of South Carolina

  • 8:05 AM – 8:07 AM ET, USA
    Introduction

    Speaker: Rodrigo O. Perez, MD, PhD – Hospital alemão Oswaldo Cruz

    Speaker: Thomas Curran, MD, MPH – Medical University of South Carolina

  • 8:07 AM – 8:15 AM ET, USA
    What Is a Ccr and Is Every Rectal Cancer Patient a Candidate for Watch and Wait?

    Speaker: Maria Widmar, MD, MPH, FACS (she/her/hers) – Memorial Sloan Kettering Cancer Center

  • 8:16 AM – 8:24 AM ET, USA
    Near-complete Response – Do We All Agree on What This Is and Should We Also Be “W” on Them?

    Speaker: Matthew F. Kalady, MD, FACS, FASCRS – The Ohio State University Wexner Medical Center

  • 8:25 AM – 8:33 AM ET, USA
    Local Regrowth's and the Risk of Distant Metastases – the Achilles Heel of Watch and Wait

    Speaker: Laura Melina Fernandez, MD (she/her/hers) – Champalimaud Foundation

  • 8:35 AM – 8:50 AM ET, USA
    Case Presentations

    Speaker: Thomas Curran, MD, MPH – Medical University of South Carolina

  • 8:50 AM – 9:05 AM ET, USA
    Case Presentations

    Speaker: Rodrigo O. Perez, MD, PhD – Hospital alemão Oswaldo Cruz